Extrapyramidal Symptoms in Children on Atypical Antipsychotic Drugs [9]

Journal of Clinical Psychopharmacology

Volumn 23, Issue 6, 2003, Pages 675-677

  Sathpathy, Sanjoy ^a   Winsberg, Bertrand ^a  

^a Brookdale Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZATROPINE; COG WHEEL PHENOMENON; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG; ZIPRASIDONE;

AGGRESSIVENESS; BEHAVIOR DISORDER; BINDING AFFINITY; CHILD; CHILD BEHAVIOR; CONFUSION; DISORIENTATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG MEGADOSE; DRUG OVERDOSE; DRUG RECEPTOR BINDING; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FASCICULATION; GAIT DISORDER; HOT FLUSH; HUMAN; HYPERSALIVATION; LETTER; MENTAL DEFICIENCY; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; RAGE; SIDE EFFECT; TREMOR; VERTIGO;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; CHILD; DIBENZOTHIAZEPINES; FEMALE; HUMANS; MALE; PIPERAZINES; THIAZOLES;

EID: 0345283355     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000096244.29231.e1     Document Type: Letter

References (17)

1. Stip E. Novel anti-psychotics: Issues and controversies. Typicality of atypical antipsychotics. Journal Psychiatry Neuroscience. 2000;25:137-153.
2. Salee FR, Kurlan R, Goetz CG, et al. Ziprasidone treatment of children and adolescent with Tourette's syndrome: A pilot study. J Am Acad Child Adolesc Psych. 2000;39:3,48:292-299.
3. Nicholson R, Awad G, Sloman L. An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psychiatry. 1998;37:360-363.
4. McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347:341-321.
5. Aman MG, Smedt GD, Derivan A, et al. Double-blind, placebo controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J. Psychiatry. 2002;159:1337-1346.
6. The Risperidone Conduct Study Group. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psychiatry. 2002;41:1026-1036.
7. Tandon R. Introduction. Br J Clin Pharmacol. 2000;49(suppl. 1):1S-3S.
8. Rollema H, Lu Y, Schimdt AW, et al. 5HT1A receptor activation contributes to Ziprasidone induced Dopamine release in the rat prefrontal cortex. Biol Psych. 2000;48:229-237.
9. Pfizer report. Geodon. Package insert, 2002, Groton, CT, Pfizer.
10. Keck PE, McElroy SL, Arnold LM. Ziprasidone. A new atypical anti-psychotic. Expert Opinion. Pharmacother. 2001;2:1033-1041.
11. Burton S, Heslop K, Harrison K, et al. Ziprasidone overdose. Am J Psychiatry. 2000;157:835.
12. Rao JJ, Norton JW. Acute dystonia with quetiapine. Clin Neuropharmacol. 2000;23:229-230.
13. Targum SD, Abbot JL. Efficacy of quetiapine in Parkinson's patients with psychosis. J Clin Psychopharm. 2000;20:54-60.
14. Sommer BR. Quetiapine induced extra pyramidal side effects in patients with Parkinson's disease: case report. J Geriatr Psychiatry Neurol. 2001;14:99-100.
15. An-Waneen R. Neuroleptic Malignant Syndrome Associated with Quetiapine. Can Journal Psych. 2000;45:764-765.
16. Stephenson CME, Bigliani V, Jones HM, et al. Br J Psych. 2000;177:408-415.
17. Kapur S, Zipursky R, Jones C, et al. A positron emission tomography study of quetiapine in schizophrenia. Arch Gen Psychiatry. 2000;57:553-559.